quinta-feira, 16 de julho de 2015

Multiple Sclerosis

Neuropsychological, Balance, and Mobility Risk Factors for Falls in People With Multiple : A Prospective Cohort Study


, ,
 Simon C. Gandevia, PhD, DSc
,
 Stephen R. Lord, PhD, DSccorrespondence


Abstract

Objectives

To determine whether impaired performance in a range of vision, proprioception, neuropsychological, balance, and mobility tests and pain and fatigue are associated with falls in people with multiple sclerosis (PwMS).

Design

Prospective cohort study with 6-month follow-up.

Setting

A multiple sclerosis (MS) physiotherapy clinic.

Participants

Community-dwelling people (N=210; age range, 21–74y) with MS (Disease Steps 0–5).

Interventions

Not applicable.

Main Outcome Measures

Incidence of falls during 6 months' follow-up.

Results

In the 6-month follow-up period, 83 participants (39.7%) experienced no falls, 57 (27.3%) fell once or twice, and 69 (33.0%) fell 3 or more times. Frequent falling (≥3) was associated with increased postural sway (eyes open and closed), poor leaning balance (as assessed with the coordinated stability task), slow choice stepping reaction time, reduced walking speed, reduced executive functioning (as assessed with the difference between Trail Making Test Part B and Trail Making Test Part A), reduced fine motor control (performance on the 9-Hole Peg Test [9-HPT]), and reported leg pain. Increased sway with the eyes closed, poor coordinated stability, and reduced performance in the 9-HPT were identified as variables that significantly and independently discriminated between frequent fallers and nonfrequent fallers (model χ23=30.1, P<.001). The area under the receiver operating characteristic curve for this model was .712 (95% confidence interval, .638–.785).

Conclusions

The study reveals important balance, coordination, and cognitive determinants of falls in PwMS. These should assist the development of effective strategies for prevention of falls in this high-risk group.

Multiple sclerosis (MS) is a chronic, lifelong, progressive neurologic disease with onset usually in early adulthood. MS lesions can influence strength, sensation, cognition, vision, and coordination, all of which may contribute to balance and fall risk.1, 2 People with MS (PwMS) are known to be at high risk for falls, as exemplified by epidemiologic studies that report that approximately 50% to 60% of PwMS fall 1 or more times over 3 to 12 months.3, 4, 5, 6, 7, 8, 9, 10
Several studies have assessed fall risk in PwMS. Identified risk factors for falls to date include advanced disease status,7,8, 9 balance or mobility impairments,3, 4, 5, 9, 11, 12 impaired forward limits of stability,8 visually dependent sway,8 use of walking aids,3, 5, 12 weakness in the lower limbs,5 fear of falling,4, 6 poor concentration or forgetfulness, urinary incontinence,4 and fatigue.10 Taken together, studies have highlighted the multifactorial nature of falls in this patient population. However, most studies were conducted in small samples (n<100) with falls as an outcome measure,7, 8, 11 and most relied on retrospective data on falls reported by participants.3, 4, 5, 6 Of those with prospective designs, the follow-up of participants has been short (3mo).7, 8, 9, 11
Previous studies have also used only a limited range of tests to assess potential risk factors for falls. We hypothesized that fall risk factors in MS are multifaceted. Therefore, concurrent examination of a broad set of neuropsychological, physical, and functional mobility measures is necessary to identify key explanatory and modifiable risk factors and to assess the relative importance of each factor in predisposing PwMS to falls. With this hypothesis, we aimed to extend previous work by administering a multidomain risk factor assessment to a sample of more than 200 community-living PwMS, and to determine prospectively the fall outcomes over 6 months. Such findings may elucidate why PwMS fall, and assist in the development of fall prevention strategies.

Methods


Design

This was a prospective cohort study with 6-month follow-up.

Participants

A total of 210 community-dwelling PwMS, aged 21 to 74 years, were recruited from patients who were referred for a physiotherapy assessment at an MS clinic site in Sydney, Australia. Participants were included if they were older than 18 years, had received a diagnosis of MS (any type), and were able to stand unsupported for 30 seconds and walk 10m with or without an aid (ie, at Disease Steps 0–5; appendix 113). The exclusion criterion was an inability to understand instructions relating to the physical assessment because of impaired cognitive function or insufficient English.
The study was approved by the Human Research Ethics Committee, University of New South Wales. Participation was voluntary, and informed consent was obtained from all participants before assessment.

Assessments

The test measures used in this study were selected to encompass the major sensorimotor, balance, and neuropsychological factors required for safe mobility. All were functional in nature, designed to assess impairments in performance. The tests were administered in 1 session lasting approximately 1 hour.

Sensorimotor function

Visual contrast sensitivity was assessed using the Melbourne Edge Test.14 Proprioception was measured with participants sitting using a lower limb–matching task.14 Errors were recorded using a protractor inscribed on a vertical clear acrylic sheet (60×60×1cm) placed between the legs. Maximal isometric quadriceps strength was measured in both legs while participants were seated on a high chair (so that feet did not touch the floor) with the hips and knees flexed to 90°. A strain gauge was fixed horizontally with straps on the lower shin, after which the participant was given a total of 3 attempts for each leg to push against the strap as forcefully as possible.14

Speed and coordination

Reaction time was assessed with a light as the stimulus and a finger press as the response.14 Participants had 10 practice trials and 10 experimental trials, with reaction time recorded in milliseconds. Fine motor control was examined with the timed 9-Hole Peg Test (9-HPT),15 in which seated participants pick up 9 pegs from a shallow container one at time as quickly as possible, place them in 9 holes, and then remove them again as quickly as possible one at a time, replacing them in the container. One practice trial with the dominant hand is followed by 1 timed trial each with the dominant and then the nondominant hand (with the average time taken as the test measure).

Standing and leaning balance

Postural sway (displacements of the body at the level of the waist) was assessed using a swaymeter with demonstrated high external validity and reliability.14, 16, 17 Testing was performed with participants standing on the floor and on a medium-density foam rubber mat (65×65×15cm thick) with eyes open and closed. Controlled leaning balance was measured using 2 tests with demonstrated validity and reliability: the maximal balance range and coordinated stability tests.17 In these tests, the swaymeter was attached anteriorly to the participant. In the maximal balance range test, participants were required to lean as far forward and as far back as possible without moving the feet or bending at the hips. Participants had 3 attempts at the test, with the highest anterior-posterior range taken as the test result. The coordinated stability test required each participant to adjust balance by leaning or rotating the body without moving the feet, so that the pen followed and remained within the borders of a 1.5-cm-wide convoluted track. A total error score was calculated by summing the number of occasions that the pen failed to stay within the path; 5 points were accrued for a cut corner and 1 for a crossed side. Participants performed 1 practice trial before the experimental trial.

Stepping and mobility

Stepping was assessed with the choice stepping reaction time test.18 For this test, participants stood on a nonslip black mat (0.8×1.2m) marked with 4 rectangular panels (32×13cm), 1 in front of each foot and 1 to the side of each foot. Participants were instructed to step onto specific rectangle panels in sequence as quickly as possible, using the left foot only for the 2 left panels (front and side) and the right foot only for the 2 right panels. Walking speed over 10m was assessed with and without a secondary cognitive task. To allow for acceleration and deceleration, 2m was provided at either end of a 10-m marked course. The secondary cognitive task was counting backward by threes starting at 100.

Neuropsychological assessment

Cognitive processing was assessed using the Trail Making Test (TMT),19 including Part A (TMT-A) that tests simple attention and Part B (TMT-B) that tests complex attention. In TMT-A, participants were asked to draw lines connecting mixed numbered circles in numerical order. TMT-B included a similar task, but the circles contained numbers and letters (eg, 1-A-2-B). Total time to complete each test was recorded. The difference between parts A and B (TMT B-A) was calculated to remove the motor speed element from the test evaluation, leaving an estimate of executive function.19

Pain and fatigue

Pain was assessed with a question asking whether participants currently had leg pain. Self-reported fatigue was assessed with the item from the Fatigue Severity Scale20 that asked whether fatigue affects physical performance. Participants who quite or very strongly agreed with the above statement were classified as having limiting fatigue.

Physiological Profile Assessment fall risk score

The Physiological Profile Assessment (PPA) fall risk index score is composed of weighted values from 5 of the sensorimotor and balance measures described above: visual contrast sensitivity, lower limb proprioception, knee extension strength, reaction time, and sway on the foam surface with eyes open. In studies of older people, PPA scores have been able to discriminate between multiple and nonmultiple fallers with accuracies up to 75%, with scores of less than 0 indicating a low risk of falling, 0 to 1 indicating a mild risk, 1 to 2 indicating a moderate risk, and scores of ≥2 indicating a high risk of falling.14

Falls follow-up

A fall was defined as “unintentionally coming to the ground or some lower level and other than as a consequence of sustaining a violent blow, loss of consciousness, sudden onset of paralysis as in stroke or an epileptic seizure.”21 After baseline assessment, the number of falls sustained by each person was monitored prospectively over 6 months by the use of monthly falls diaries, with monthly telephone follow-up if required.22 Previous studies14, 23 of older people have found that recurrent falls (≥2 falls within a year) are more likely to indicate physiological impairments and chronic conditions, and are therefore more clinically important. Because of the very high frequency of falls in PwMS,3, 4, 5, 6, 7, 8, 9,10 frequent fallers were defined as those who had ≥3 falls in the follow-up period.

Power analysis

A power analysis was based on a study of physiological risk factors for falls in a population of older people,24 which indicated that a sample size of 200 would be sufficient for detecting differences in outcome measures between frequent faller and nonfrequent faller groups. A sample of this size was also considered sufficient for not violating assumptions between the number of participants required for multivariate logistic regression modeling25—that is, we estimated that 60 (30%) of the 200 participants would have frequent (≥3) falls during the 6-month falls diary collection period, allowing for up to 6 predictors to be included in our models.

Statistical analysis

Continuously scaled data with right-skewed distributions were log-transformed before analysis. Bivariate correlations between variables were calculated using Pearson and Spearman correlation coefficients. Nonfrequent and frequent fallers were initially compared on the test measures using the relative risk statistic and independent t tests. Logistic regression analysis was then conducted to determine the best set of discriminators. To identify significant and independent fall risk factors across multiple domains, the variable with the strongest association with falls from each of the following domains—sensorimotor function, standing balance, leaning balance, functional mobility, executive function, and pain/fatigue—was entered into the multivariate model. No adjustments for MS disease severity or other medical conditions were made, since our underlying premise is a functional/physiological one. As such, we maintain that the effects of any medical conditions (diagnosed or not) would manifest in 1 or more of the physiological and neuropsychological measures assessed,14 and that the inclusion of medical conditions in the multivariate models may result in overadjusting and dilution of important explanatory findings.26 Marker variables such as previous falls that do not assist in explaining why falls occur were also not entered as possible predictors. A forward stepwise procedure was used in the logistic regression, and variables were retained in the final model if their significance was <.05. Receiver operating characteristic (ROC) analyses were then undertaken to investigate the efficacy of the classification function. The data were analyzed with SPSSa and STATA.b

Results


Demographic, health, and lifestyle characteristics of the sample

Table 1 shows the prevalence of medical conditions, mobility status, medication use, falls in past year, and injuries incurred from falls for the study sample.
Table 1Demographic characteristics of participants (N=210)
CharacteristicsValues
Mean age (y)50.8±11.1 (21–74)
Women152 (72.4)
Men58 (27.6)
Mean disease duration (y)9.9±7.0 (0.2–31.1)
Disease type
 Primary progressive26 (12.3)
 Relapsing-remitting121 (57.3)
 Secondary progressive27 (12.8)
 Unknown36 (17.1)
Disease Steps
 028 (13.3)
 157 (27.1)
 225 (11.9)
 337 (17.6)
 437 (17.6)
 526 (12.4)
Mobility aids
 No aids108 (51.2)
 Walking stick58 (27.5)
 Frame or rollator18 (8.5)
 Crutches7 (3.3)
 Ankle brace5 (2.4)
 Others (wheelchair, scooter, etc)14 (6.7)
MS-modifying therapy
 None73 (34.6)
 Interferon-beta 1a48 (22.8)
 Interferon-beta 1b21 (10.0)
 Natalizumab21 (10.0)
 Not sure9 (4.6)
Antispasticity medication
 None165 (78.2)
 Baclofen30 (14.2)
 Valium6 (2.8)
 Botulinum toxin2 (0.9)
 Not sure7 (3.3)
Falls and fall-related injuries in past 12mo
 Falls2.5±2.1 (0–6)
 One plus fall injury71 (33.6)
 One plus fall-related fracture34 (16.2)
NOTE. Values are mean ± SD (minimum–maximum) or n (%).
See appendix 1 for description of Disease Steps.13

Associations among the assessment measures, age, and disease severity

Table 2 shows the correlations between the test measures and age and disease severity. Impaired performances in most tests were significantly associated with increased age and disease severity.
Table 2Correlations between falls reported by participants in 6-month follow-up and test measures, and age and disease severity (N=210)
Falls/TestsAge (r)Disease Step (ρ)
Falls reported in 6 mo−.029.367
TMT-A (s).231.272
TMT-B (s).192.342
TMT B-A (s).118.313
9-HPT (s).131.386
Visual contrast sensitivity (dB)−.096−.087
Proprioception (deg error).109.212
Quadriceps strength (kg)−.378−.237
Simple reaction time (ms).246.207
Sway on floor: eyes open.243.448
Sway on floor: eyes closed.177.458
Sway on foam: eyes open.187.456
Sway on foam: eyes closed.113.443
Maximal balance range−.194−.434
Coordinated stability (error score).218.565
Stepping choice reaction time (s).205.658
10-m walk (s).289.720
10-m walk with dual task (s).244.603
PPA.271.445
N=209.
P<.01.
Path length in mm
§P<.05.

Incidence of falls

Of the 210 participants, 209 had complete incidence information for falls at the 6-month follow-up. Of these, 83 participants (39.7%) reported no falls, 57 (27.3%) reported 1 or 2 falls only, 45 (21.5%) reported 3 to 9 falls, and 24 (11.5%) reported 10 or more falls (range, 10–210) (fig 1). A total of 1397 falls occurred. One hundred twenty-one participants (57.9%) sustained 1 or more fall-related injuries: 78 bruises (37.3%), 50 cuts/grazes (23.9%), 21 sprains/strains (10.0%), 5 dislocations (2.4%), and 6 (2.9%) fractures. Frequent fallers had higher average ± SD MS Disease Step levels than nonfrequent fallers (3.8±0.8 and 3.1±1.2, respectively; t1,200=4.36, P<.001) but were of similar age ± SD (52.1±10.5y and 50.1±11.4y, respectively; t1,207=1.26, P=.21).

Thumbnail image of Fig 1. Opens large image

Fig 1

Number of falls reported by participants during 6-month follow-up. Among frequent (≥3) fallers, 21.5% reported 3 to 9 falls, while 11.5% reported 10 falls or more.

Associations among the assessment measure and frequent falls

Table 3 shows the mean scores plus SDs for the continuously scored test measures for the nonfrequent and frequent fallers. Frequent falling was associated with impaired balance, as indicated by 4 sway tests and 2 leaning balance tests (maximal balance range and coordinated stability), slow stepping and walking (with and without a dual task), slow psychomotor speed (TMT-A scores), reduced executive functioning (TMT-B and TMT B-A scores), reduced fine motor control (9-HPT times), and high PPA fall risk scores. Frequent falling was not significantly associated with reduced visual contrast sensitivity, poor proprioception, reduced lower limb strength, or slow reaction time.
Table 3Mean scores of tests for frequent (≥3) fallers and nonfrequent (<3) fallers
TestFrequent FallersNonfrequent FallersP
TMT-A (s)50.7±32.040.3±18.8<.01
TMT-B (s)123.6±73.598.0±51.9<.01
TMT B-A (s)72.9±54.457.7±40.5<.01
9-HPT (s)32.5±13.226.7±8.5<.05
Visual contrast sensitivity (dB)21.5±2.121.9±1.7NS
Proprioception (deg error)4.2±2.33.8±2.4NS
Quadriceps strength (kg)27.6±2.330.1±12.2NS
Simple reaction time (ms)327±131310±110NS
Sway Eyes open on floor (mm)217±159140±109NS
Eyes closed on floor (mm)379±247260±221<.001
Eyes open on foam (mm)453±252287±210<.001
Eyes closed on foam (mm)855±334597±376<.001
Maximal balance range (mm)126±62150±50<.001
Coordinated stability (error score)30.1±22.018.1±16.4<.01
Stepping choice reaction time (s)40.6±20.836.0±18.1<.001
10-m walk (s)15.3±12.011.7±8.7<.001
10-m walk with dual task (s)22.1±18.616.0±12.8<.001
PPA fall risk score2.70±1.381.83±1.50<.001
NOTE. Values are mean ± SD or as otherwise indicated. Impaired performance is indicated by low scores in the visual contrast sensitivity, quadriceps strength tests, and maximal balance, and high scores in all other tests.
Abbreviation: NS, not significant.
P values were derived using independent group t tests.
A significantly higher proportion of frequent fallers (56.1%) reported lower limb pain than nonfrequent fallers (40.1%) (relative risk, 1.54; 95% confidence interval [CI], 1.03–2.30). There was also a trend indicating that more frequent fallers (59.1%) than nonfrequent fallers (45.3%) reported fatigue affecting their physical performance (relative risk, 1.46; 95% CI, .97–2.19).
Logistic regression identified sway with eyes closed, poor coordinated stability, and reduced fine motor control as the variables that significantly and independently discriminated between participants who did and did not experience frequent falls (model χ23=30.1, P<.001). The adjusted odds ratios for SD decrements in performance for these tests were 1.59 (95% CI, 1.11–2.23) for sway, 1.41 (95% CI, 1.01–1.97) for coordinated stability, and 1.45 (95% CI, 1.02–2.05) for fine motor control. These variables all remained significant when age was also included in the multivariate model. The area under the ROC curve for the 3-variable model was .712 (95% CI, .638–.785). In comparison, the area under the ROC curve for the PPA fall risk score derived in studies of older people was .681 (95% CI, .605–.756).

Discussion

This study aimed to identify fall risk factors in a large sample of community-dwelling PwMS to achieve a greater understanding of important contributors to fall risk in this population. A range of neuropsychological, physical, and functional mobility measures was significantly associated with prospectively measured fall rates, with impaired standing and leaning balance and reduced fine motor control being significantly and independently associated with falls in a multivariate model.
Reduced balance has previously been identified as a significant factor contributing to falls in MS.3, 4, 5, 8, 11, 12 In the present study, frequent fallers performed significantly worse than nonfrequent fallers in all balance tests including the 4 postural sway tests on the floor and the foam with eyes open or closed. Further, in the multivariate logistic regression analysis, 2 complementary balance tests—postural sway with eyes closed on the floor and coordinated stability—were significant and independent predictors of frequent falls. Increased sway assesses quiet standing postural control, is associated with reduced peripheral sensation and quadriceps weakness,27 and is a surrogate measure of sensorimotor performance.14, 28 In contrast, coordinated stability is a voluntary, dynamic measure involving control of the center of mass while leaning to achieve postural control near the limits of the base of support. Both measures contributed to the final model, suggesting that each is an important and independent contributor to fall risk. Importantly, these 2 balance tests are “low tech,” have good test-retest reliability,14 and can be easily used in clinical settings.
Reduced fine motor control, as assessed by poor performance on the 9-HPT, was the third measure included in the multivariate model for frequent falls. The 9-HPT provides a quantitative measure of arm and hand function and is increasingly used in MS clinical trials. It has been chosen as 1 of 3 components of the Multiple Sclerosis Functional Composite.29 Poor performance on the 9-HPT may result from a range of pathophysiological changes, including impaired upper limb strength, sensation, and coordination. The 9-HPT may also serve as a marker of the extent of disease affecting complex upper extremity function. Slow performance on the 9-HPT is associated with abnormalities in the corpus callosum in PwMS30 and with changes in the interhemispheric white matter pathway connecting bilateral supplementary motor areas and other areas involved in planning and movement control.31
Several additional measures (slow choice stepping reaction time, gait speed, reduced executive functioning, the presence of pain) were significantly associated with falls in univariate analyses. These variables were not included in the multiple regression model partly because of their associations with the included balance and motor control measures. However, as these variables reflect specific abilities directly required for safe mobility, they also warrant attention in considering strategies for fall prevention in PwMS. In contrast, some measures that discriminate between elderly fallers and nonfallers, including vision (as assessed with a test of contrast sensitivity), lower limb proprioception, knee extension strength, and simple reaction time,14 appear to be less important in discriminating between frequent and nonfrequent fallers in this sample of PwMS. For visual contrast sensitivity and knee extension strength, this may be due to adequate performance in both frequent and nonfrequent fallers in this group of PwMS, although leg flexor-extensor weakness has been identified as a predictor for recurrent fallers in women with MS.8 However, for lower limb proprioception and simple reaction time, the converse was evident, in that performances for both frequent and nonfrequent fallers above that found in older people at increased risk of falls.18, 32 It may be that PwMS are able to adapt to these deficiencies and avoid falling, provided they do not have concomitant balance and coordination impairments.
The PPA fall risk measure also discriminated significantly between the frequent and nonfrequent fallers in PwMS, with the area under the ROC curve not far below that of the MS-specific model derived here. These findings complement those of Gunn et al,9 in which the authors found a model including the PPA, Ashworth Scale for spasticity had an area under the ROC curve of .73.

Study limitations

Strengths of this study include the broad range of sensorimotor and balance measures and the rigorous prospective falls surveillance. However, the study had a number of limitations. First, we measured the strength of only 1 muscle group: the knee extensors. Weakness in other lower limb muscle groups is common in MS and may be associated with a higher fall risk in this group. Second, we used only single questionnaire items for the measures of pain and fatigue. More rigorous assessment of these measures may have uncovered stronger associations with fall risk. Finally, the inclusion of other signs and symptoms in the present study, such as joint contractures and spasticity, may have further improved our explanatory model of fall risk in PwMS. Further research aimed at identifying cut points for strength and other measures, as well as comparing performance scores obtained in PwMS with normative data, may also provide useful additional information regarding fall risk in this population.

Conclusions

The study findings elucidate important balance, coordination, and cognitive determinants of falls in PwMS. Multifaceted fall prevention strategies have been found to be effective in the general older community, but to date, only preliminary fall prevention interventions have been undertaken in PwMS.33, 34, 35 Future studies that assess intervention strategies targeting falls should consider fall risk factors that are potentially amenable to intervention (eg, impaired coordination, balance, stepping, and gait), as well as factors that need to be considered in delivery of an intervention (eg, executive function impairments). The findings of this large prospective study suggest that assessment of physical and cognitive fall risk factors is required in clinical practice to tailor intervention strategies to the fall risk profile of individuals with MS.

Suppliers

  • a.
    SPSS Inc, 233 S Wacker Dr, 11th Fl, Chicago, IL 60606.
  • b.
    StataCorp LP, 4905 Lakeway Dr, College Station, TX 77845.

Acknowledgments

We thank Multiple Sclerosis Limited and physiotherapists of Multiple Sclerosis Limited for assisting us in recruitment and assessment of participants, and Ms. Connie Severino for her enormous efforts and time for data entry.

Appendix 1. Disease Steps

Methods: For Disease Steps, classification of a patient is determined by history and neurologic examination as well as course of MS. The scale consists of the following categories:
  • 0 = Normal: functionally normal with no limitations on activity or lifestyle. Patients may have minor abnormality on examination, such as nystagmus or an extensor plantar. The course is relapsing-remitting with a return to baseline with or without treatment. These patients are not treated with any ongoing symptomatic therapy for MS.
  • 1 = Mild disability: mild symptoms or signs. These patients have mild but definite findings such as sensory abnormalities, mild bladder impairment, minor incoordination, weakness, or fatigue. There is no visible abnormality of gait. The pattern of disease is relapsing-remitting, but patients may not have a full return to baseline after attacks. These patients may use ongoing symptomatic therapy such as amantadine, baclofen, or oxybutynin.
  • 2 = Moderate disability: the main feature is a visibly abnormal gait, but patients do not require ambulation aids. The pattern of disease is relapsing-remitting or progressive.
  • 3 = Early cane: intermittent use of cane (or other forms of unilateral support including splint, brace, or crutch). These patients use unilateral support primarily for longer distances but are able to walk at least 25ft without it. The pattern of disease is relapsing-remitting or progressive.
  • 4 = Late cane: these patients are dependent on a cane or other forms of unilateral support and cannot walk 25ft without such support (eg, these patients may hang on to furniture inside their homes or touch the wall when walking in clinic). Patients may use a scooter for greater distances (eg, malls). The pattern of disease is relapsing-remitting or progressive.
  • 5 = Bilateral support: patients require bilateral support to walk 25ft (eg, 2 canes or 2 crutches or a walker). They may use a scooter for greater distances. The pattern of disease is relapsing-remitting or progressive.
  • 6 = Confined to wheelchair: patients are essentially confined to a wheelchair or scooter. They may be able to take a few steps but are unable to ambulate 25ft, even with bilateral support. They may show further progression including worsening hand function or inability to transfer independently.
  • U = Unclassifiable: this category is used for patients who do not fit the above classification (eg, significant cognitive or visual impairment, overwhelming fatigue, or significant bowel or bladder impairment in an otherwise minimally impaired patient).
Reprinted by Permission of SAGE from: Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler 1999;5:349-54. Copyright © 1999 by SAGE Publications.

References

  1. Goodin, D.S. and Hauser, S.L. Multiple sclerosis and other demyelinating diseases. in: D.L. Longo, A.S. Fauci, D.L. Kasper, S.L. Hauser, J.L. Jameson, J. Loscalzo (Eds.) Harrison's principles of internal medicine18th ed. McGraw-HillNew York2012
  2. Frzovic, D., Morris, M.E., and Vowels, L. Clinical tests of standing balance: performance of persons with multiple sclerosis. Arch Phys Med Rehabil200081215–221
  3. Cattaneo, D., De Nuzzo, C., Fascia, T., Macalli, M., Pisoni, I., and Cardini, R. Risks of falls in subjects with multiple sclerosis. Arch Phys Med Rehabil200283864–867
  4. Finlayson, M.L., Peterson, E.W., and Cho, C.C. Risk factors for falling among people aged 45 to 90 years with multiple sclerosis. Arch Phys Med Rehabil2006871274–1279 (quiz 1287)
  5. Matsuda, P.N., Shumway-Cook, A., Bamer, A.M., Johnson, S.L., Amtmann, D., and Kraft, G.H. Falls in multiple sclerosis. PM R20113624–632 (quiz 632)
  6. Peterson, E.W., Cho, C.C., von Koch, L., and Finlayson, M.L. Injurious falls among middle aged and older adults with multiple sclerosis. Arch Phys Med Rehabil2008891031–1037
  7. Nilsagard, Y., Lundholm, C., Denison, E., and Gunnarsson, G. Predicting accidental falls in people with multiple sclerosis: a longitudinal study. Clin Rehabil200923259–269
  8. Kasser, S.L., Jacobs, J.V., Foley, J.T., Cardinal, B.J., and Maddalozzo, G.F. A prospective evaluation of balance, gait, and strength to predict falling in women with multiple sclerosis. Arch Phys Med Rehabil2011921840–1846
  9. Gunn, H., Creanor, S., Haas, B., Marsden, J., and Freeman, J. Risk factors for falls in multiple sclerosis: an observational study. Mult Scler2013 Apr 30([Epub ahead of print])
  10. Coote, S., Hogan, N., and Franklin, S. Falls in people with multiple sclerosis who use a walking aid: prevalence, factors, and effect of strength and balance interventions. Arch Phys Med Rehabil201394616–621
  11. Prosperini, L., Fortuna, D., Gianni, C., Leonardi, L., and Pozzilli, C. The diagnostic accuracy of static posturography in predicting accidental falls in people with multiple sclerosis. Neurorehabil Neural Repair2013;2745–52
  12. Gunn, H.J., Newell, P., Haas, B., Marsden, J.F., and Freeman, J.A. Identification of risk factors for falls in multiple sclerosis: a systematic review and meta-analysis. Phys Ther201393504–513
  13. Hohol, M.J., Orav, E.J., and Weiner, H.L. Disease steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology199545251–255
  14. Lord, S.R., Menz, H.B., and Tiedemann, A. A physiological profile approach to falls risk assessment and prevention. Phys Ther200383237–252
  15. Mathiowetz, V., Weber, K., Kashman, N., and Volland, G. Adult norms for the Nine Hole Peg Test of finger dexterity. Occup Ther J Res1985533
  16. Sturnieks, D.L., Arnold, R., and Lord, S.R. Validity and reliability of the Swaymeter device for measuring postural sway. BMC Geriatr20111163
  17. Lord, S.R., Ward, J.A., and Williams, P. Exercise effect on dynamic stability in older women: a randomized controlled trial. Arch Phys Med Rehabil199677232–236
  18. Lord, S.R. and Fitzpatrick, R.C. Choice stepping reaction time: a composite measure of falls risk in older people. J Gerontol A Biol Sci Med Sci200156M627–M632
  19. Lezak, M., Howieson, D., and Loring, D. Neuropsychological assessment. 4th ed. Oxford University PrNew York2004
  20. Krupp, L.B., LaRocca, N.G., Muir-Nash, J., and Steinberg, A.D. The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol1989461121–1123
  21. Gibson, M.J., Andres, R.O., Isaacs, B., Radebaugh, T., and Worm-Petersen, J. The prevention of falls in later life. A report of the Kellogg International Work Group on the Prevention of Falls by the Elderly. Dan Med Bull1987;341–24 (p 4.)
  22. Lamb, S.E., Jorstad-Stein, E.C., Hauer, K., and Becker, C. Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe Consensus. J Am Geriatr Soc2005531618–1622
  23. Nevitt, M.C., Cummings, S.R., Kidd, S., and Black, D. Risk factors for recurrent nonsyncopal falls. A prospective study. JAMA19892612663–2668
  24. Sturnieks, D.L., Tiedemann, A., Chapman, K., Munro, B., Murray, S.M., and Lord, S.R. Physiological risk factors for falls in older people with lower limb arthritis. J Rheumatol2004312272–2279
  25. Concato, J., Feinstein, A.R., and Holford, T.R. The risk of determining risk with multivariable models. Ann Intern Med1993118201–210
  26. Breslow, N. Design and analysis of case-control studies. Annu Rev Public Health1982329–54
  27. Lord, S.R. and Ward, J.A. Age-associated differences in sensori-motor function and balance in community dwelling women. Age Ageing199423452–460
  28. Hughes, M.A., Duncan, P.W., Rose, D.K., Chandler, J.M., and Studenski, S.A. The relationship of postural sway to sensorimotor function, functional performance, and disability in the elderly. Arch Phys Med Rehabil199677:567–572
  29. Polman, C.H. and Rudick, R.A. The Multiple Sclerosis Functional Composite: a clinically meaningful measure of disability. Neurology201074S8–15
  30. Ozturk, A., Smith, S.A., Gordon-Lipkin, E.M. et al. MRI of the corpus callosum in multiple sclerosis: association with disability. Mult Scler201016166–177
  31. Lowe, M.J., Horenstein, C., Hirsch, J.G. et al. Functional pathway-defined MRI diffusion measures reveal increased transverse diffusivity of water in multiple sclerosis. Neuroimage2006321127–1133
  32. Lord, S.R., Ward, J.A., Williams, P., and Anstey, K.J. Physiological factors associated with falls in older community-dwelling women. J Am Geriatr Soc1994421110–1117
  33. Prosperini, L., Leonardi, L., De Carli, P., Mannocchi, M.L., and Pozzilli, C. Visuo-proprioceptive training reduces risk of falls in patients with multiple sclerosis. Mult Scler201016491–499
  34. Cattaneo, D., Jonsdottir, J., Zocchi, M., and Regola, A. Effects of balance exercises on people with multiple sclerosis: a pilot study. Clin Rehabil200721771–781
  35. Finlayson, M., Peterson, E.W., and Cho, C. Pilot study of a fall risk management program for middle aged and older adults with MS. NeuroRehabilitation200925107–115

Nenhum comentário:

Postar um comentário